Low income vs Sweden: Access to anti-retroviral drugs, female
Low income
85.2%
in 2024
Sweden
96.0%
in 2022
Low income rank
13th
Sweden rank
14th
Access to anti-retroviral drugs, female over time
- Low income
- Sweden
How they compare
Sweden currently reports 96.0% against 85.2% in Low income, a difference of 10.8%.
That makes Sweden's figure about 1.1 times Low income's.
Across all 23 years both countries report, Sweden has been ahead every year.
Low income ranks 13th and Sweden ranks 14th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Low income | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 41.9% | 36.7% | Sweden |
| 2010s | 46.8% | 89.5% | 42.7% | Sweden |
| 2020s | 75.8% | 95.7% | 19.9% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Low income or Sweden?
- Sweden, at 96.0% against 85.2% in Low income as of 2022.
- What is the difference in access to anti-retroviral drugs, female between Low income and Sweden?
- 10.8%, with Sweden ahead.
- How many years of comparable data are there for Low income and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Low income and Sweden rank globally for access to anti-retroviral drugs, female?
- Low income ranks 13th and Sweden ranks 14th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.